Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 499209-19-7 | MDL No. : | MFCD03714529 |
Formula : | C9H13N3O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QQVHAVBZUUKKSU-UHFFFAOYSA-N |
M.W : | 211.22 | Pubchem ID : | 135455109 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.44 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 54.1 |
TPSA : | 98.33 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.31 cm/s |
Log Po/w (iLOGP) : | 1.76 |
Log Po/w (XLOGP3) : | 0.39 |
Log Po/w (WLOGP) : | 0.19 |
Log Po/w (MLOGP) : | -0.03 |
Log Po/w (SILICOS-IT) : | 0.68 |
Consensus Log Po/w : | 0.6 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.43 |
Solubility : | 7.9 mg/ml ; 0.0374 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.02 |
Solubility : | 2.01 mg/ml ; 0.00953 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.0 |
Solubility : | 2.12 mg/ml ; 0.01 mol/l |
Class : | Soluble |
PAINS : | 1.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.39 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 6214-46-6 ]
Ethyl 2-(4-hydroxypyrimidin-5-yl)acetate
Similarity: 0.86
[ 869891-41-8 ]
Methyl 2,4-dihydroxy-6-methylpyrimidine-5-carboxylate
Similarity: 0.70
[ 19178-21-3 ]
2-Methyl-5,6,7,8-tetrahydroquinazolin-4-ol
Similarity: 0.64
[ 858956-25-9 ]
2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid
Similarity: 0.62
[ 6214-46-6 ]
Ethyl 2-(4-hydroxypyrimidin-5-yl)acetate
Similarity: 0.86
[ 81633-29-6 ]
Ethyl 2-amino-4-methylpyrimidine-5-carboxylate
Similarity: 0.73
[ 869891-41-8 ]
Methyl 2,4-dihydroxy-6-methylpyrimidine-5-carboxylate
Similarity: 0.70
[ 2164-66-1 ]
Methyl 2-aminopyrimidine-4-carboxylate
Similarity: 0.67
[ 863032-29-5 ]
Methyl 2-(pyrimidin-4-yl)acetate
Similarity: 0.66
[ 81633-29-6 ]
Ethyl 2-amino-4-methylpyrimidine-5-carboxylate
Similarity: 0.73
[ 2164-66-1 ]
Methyl 2-aminopyrimidine-4-carboxylate
Similarity: 0.67
[ 57401-76-0 ]
Ethyl 2-aminopyrimidine-5-carboxylate
Similarity: 0.65
[ 308348-93-8 ]
Methyl 2-aminopyrimidine-5-carboxylate
Similarity: 0.62
[ 6214-46-6 ]
Ethyl 2-(4-hydroxypyrimidin-5-yl)acetate
Similarity: 0.86
[ 81633-29-6 ]
Ethyl 2-amino-4-methylpyrimidine-5-carboxylate
Similarity: 0.73
[ 869891-41-8 ]
Methyl 2,4-dihydroxy-6-methylpyrimidine-5-carboxylate
Similarity: 0.70
[ 2164-66-1 ]
Methyl 2-aminopyrimidine-4-carboxylate
Similarity: 0.67